Catawba Clinical Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Charlotte NC United States (2014)

Organization Overview

First Clinical Trial
2014
NCT01742637
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Catawba | Catawba Research | Catawba Research, LLC | http://catawbaresearch.com/contact/

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 3)

Facies (Phase 3)

Lice Infestations (Phase 1)

Psoriasis (Phase 2)

Rosacea (Phase 3)

Tinea (Phase 3)

Tinea Pedis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 27
  • # of Trial APIs: 14